NationsBenefits and Kinney Drugs Expand Flex Card Access in New York
NationsBenefits and Kinney Drugs Partner to Expand Flex Card Access for Rx and OTC Health Needs in New York NationsBenefits, the leading healthcare fintech and supplemental benefits platform, announced a…
FDA Accepts Bristol Myers Squibb’s NDA for Iberdomide in Relapsed or Refractory Multiple Myeloma
U.S. Food and Drug Administration Accepts Bristol Myers Squibb’s New Drug Application for Iberdomide in Patients with Relapsed or Refractory Multiple Myeloma Bristol Myers Squibb today announced that the U.S.…
BRAFTOVI Regimen from Pfizer Demonstrates Improved PFS in Advanced Colorectal Cancer
Pfizer’s BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer Pfizer Inc. today announced positive topline progression-free (PFS) survival results from Cohort 3, a separate randomized cohort of the pivotal…
ImmunityBio Advances Regulatory Collaboration at USA-Saudi Biotech Alliance Event in Saudi Arabia
ImmunityBio Reports Productive Regulatory Engagement with Saudi Food and Drug Authority at USA-Saudi Biotech Alliance Meeting Hosted by the Ministry of Investment of Saudi Arabia ImmunityBio, Inc. a commercial stage…
Nuclera, leadXpro Collaborate to Enhance Structure-Guided Drug Discovery for Membrane Protein Targets
Nuclera and leadXpro Partner to Accelerate Structure-Based Drug Design for Complex Membrane Proteins Nuclera, the biotechnology company enabling rapid access to high-quality proteins and leadXpro, a specialist in structure-based drug…
Regional Dermatology Partners with Epiphany Dermatology
Regional Dermatology Joins Epiphany Dermatology Epiphany Dermatology, a leading dermatology company committed to improving access to exceptional dermatologic care, announced today it has expanded its presence in Missouri through its partnership with…
Newron Pharmaceuticals Obtains Up to EUR 38 Million to Propel Late-Stage Evenamide Program
Newron Secures Up to EUR 38 Million to Advance Phase III Evenamide Program Newron Pharmaceuticals S.p.A. a biopharmaceutical company focused on the development of novel therapies for patients with diseases…
VB Spine Moves to Secure Exclusive Rights to Augmedics’ Spine Technology Platform
VB Spine Announces Intent to Acquire Exclusive Rights to Augmedics’ Spine Platform VB Spine LLC the largest privately held spine company, today announced it has entered into a definitive agreement to acquire…
DeciBio Consulting Unveils Data Report on Oncology Genomics Trends Across Europe
Europe Oncology Genomics Tracker Captures Oncologist Perspectives Across Major European Markets – Data Report by DeciBio Consulting LLC A new survey-based Genomics Tracker focused on the EU-5 (France, Germany, Italy, Spain, and…
Worldwide Clinical Trials Finalizes Acquisition of Catalyst Clinical Research
Worldwide Clinical Trials Completes Acquisition of Catalyst Clinical Research Worldwide Clinical Trials a global contract research organization (CRO), has completed its acquisition of Catalyst Clinical Research, LCC (“Catalyst”) – a specialized oncology CRO and scalable functional…
ECCO Data Highlight Remsima™ SC’s Ability to Restore and Sustain Disease Control After Treatment Break
New ECCO data show subcutaneous (SC) infliximab (Remsima™ SC) effectively recaptures and maintains disease control after drug holiday Celltrion, Inc. today announced new data from a post-hoc analysis of the pivotal…
Genentech Highlights Breakthrough Phase III Results for Gazyva in Autoimmune Kidney Disease
Genentech Announces Positive Phase III Results for Gazyva in Primary Membranous Nephropathy, Marking a Significant Milestone in This Autoimmune Disease Genentech, a member of the Roche Group announced today that…